.it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
on sunday morning, may 6, at 9:04 a.m., helen opened her eyes and turned to robert and took her last breath.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
.
.
.
.